Abstract

Personalized cancer therapy represents a paradigm shift in oncology, leveraging advancements in genomics and precision medicine to tailor treatments to individual patients. This approach aims to improve therapeutic efficacy, minimize adverse effects, and ultimately enhance patient outcomes. This article explores the foundational principles of personalized cancer therapy, the role of genomics in identifying actionable mutations, and the integration of precision medicine into clinical practice. We discuss the materials and methods employed in genomic profiling, the results of recent clinical trials, and the implications of these findings for future cancer treatment strategies. The article concludes with a discussion of the challenges and opportunities in the field, emphasizing the need for continued research and collaboration to realize the full potential of personalized cancer therapy.